Original Query: ALL
Previous Study | Return to List | Next Study

A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00683241
Recruitment Status : Completed
First Posted : May 23, 2008
Last Update Posted : February 26, 2013
Northwest Biotherapeutics
University of California, San Francisco
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2009
  Study Completion Date : December 2009